TY - JOUR
T1 - Management of metastatic HER2-positive breast cancer
T2 - Where are we and where do we go from here?
AU - Santa-Maria, Cesar Augusto
AU - Nye, Lauren
AU - Mutonga, Martin B.
AU - Jain, Sarika
AU - Gradishar, William J.
N1 - Publisher Copyright:
© 2016, UBM Medica Healthcare Publications. All rights reserved.
PY - 2016/2/15
Y1 - 2016/2/15
N2 - This review will summarize the current standard of care; key issues that arise when treating patients with HER2-positive disease; and developments in novel therapeutics, including small-molecule inhibitors, nanoparticles, immunotherapy, and agents targeting resistance pathways.
AB - This review will summarize the current standard of care; key issues that arise when treating patients with HER2-positive disease; and developments in novel therapeutics, including small-molecule inhibitors, nanoparticles, immunotherapy, and agents targeting resistance pathways.
UR - http://www.scopus.com/inward/record.url?scp=84959187678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959187678&partnerID=8YFLogxK
M3 - Article
C2 - 26892151
AN - SCOPUS:84959187678
SN - 0890-9091
VL - 30
JO - ONCOLOGY (United States)
JF - ONCOLOGY (United States)
IS - 2
ER -